Kevin Judice - Net Worth and Insider Trading
Kevin Judice Net Worth
The estimated net worth of Kevin Judice is at least $38 Million dollars as of 2024-12-28. Kevin Judice is the CEO of DICE Therapeutics Inc and owns about 799,685 shares of DICE Therapeutics Inc (DICE) stock worth over $38 Million. Details can be seen in Kevin Judice's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kevin Judice has not made any transactions after 2023-05-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kevin Judice
Kevin Judice Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kevin Judice owns 2 companies in total, including Cidara Therapeutics Inc (CDTX) , and DICE Therapeutics Inc (DICE) .
Click here to see the complete history of Kevin Judice’s form 4 insider trades.
Insider Ownership Summary of Kevin Judice
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CDTX | Cidara Therapeutics Inc | 2015-04-14 | director |
| DICE | DICE Therapeutics Inc | 2023-05-03 | director & CEO |
Kevin Judice Latest Holdings Summary
Kevin Judice currently owns a total of 1 stock. Kevin Judice owns 799,685 shares of DICE Therapeutics Inc (DICE) as of May 3, 2023, with a value of $38 Million.
Latest Holdings of Kevin Judice
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DICE | DICE Therapeutics Inc | 2023-05-03 | 799,685 | 47.55 | 38,025,022 |
Holding Weightings of Kevin Judice
Kevin Judice Form 4 Trading Tracker
According to the SEC Form 4 filings, Kevin Judice has made a total of 1 transactions in DICE Therapeutics Inc (DICE) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in DICE Therapeutics Inc is the sale of 13,698 shares on May 3, 2023, which brought Kevin Judice around $499,977.
Insider Trading History of Kevin Judice
- 1
Kevin Judice Trading Performance
Kevin Judice Ownership Network
Kevin Judice Owned Company Details
What does Cidara Therapeutics Inc do?
Who are the key executives at Cidara Therapeutics Inc?
Kevin Judice is the director of Cidara Therapeutics Inc. Other key executives at Cidara Therapeutics Inc include Chief Scientific Officer Leslie Tari , Chief Medical Officer Taylor Sandison , and director & President & CEO Jeffrey Stein .
Cidara Therapeutics Inc (CDTX) Insider Trades Summary
Over the past 18 months, Kevin Judice made no insider transaction in Cidara Therapeutics Inc (CDTX). Other recent insider transactions involving Cidara Therapeutics Inc (CDTX) include a net sale of 30,407 shares made by Leslie Tari , a net sale of 40,379 shares made by Taylor Sandison , and a net purchase of 58,000 shares made by Jeffrey Stein .
In summary, during the past 3 months, insiders sold 0 shares of Cidara Therapeutics Inc (CDTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 7,751 shares of Cidara Therapeutics Inc (CDTX) were sold and 11,000 shares were bought by its insiders, resulting in a net purchase of 3,249 shares.
Cidara Therapeutics Inc (CDTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cidara Therapeutics Inc Insider Transactions
Kevin Judice Mailing Address
Above is the net worth, insider trading, and ownership report for Kevin Judice. You might contact Kevin Judice via mailing address: 6310 Nancy Ridge Drive, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
